NCT03151551 A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis Status COMPLETED Phase PHASE4
NCT03104400 A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) Status COMPLETED Phase PHASE3
NCT03100253 Rheumatoid Arthritis Treatment After First Anti-TNF INvestiGation Status TERMINATED Phase PHASE4
NCT03059849 Brief Escalation of Adalimumab Treatment for Prevention of Clinical Relapse in IBD Status WITHDRAWN Phase PHASE4
NCT03016260 RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis Status TERMINATED Phase N/A
NCT02963402 Immunoregulatory Mechanisms of Treg Cells Induced by Tocilizumab Status COMPLETED Phase N/A
NCT02929251 Randomized Trial Comparing Efficacy of Adalimumab, Anakinra and Tocilizumab in Non-infectious Refractory Uveitis Status COMPLETED Phase PHASE2
NCT02927353 A Phase 1 Pharmacokinetic Bioequivalence Study of DMB-3113 and Adalimumab in Healthy Japanese Adult Male Subjects Status COMPLETED Phase PHASE1
NCT02912247 Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02904902 Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa Status COMPLETED Phase PHASE3
NCT02897115 A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine Treatment Status TERMINATED Phase PHASE4
NCT02893254 Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT02889796 Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE3
NCT02878161 Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World" Status UNKNOWN Phase PHASE4
NCT02878083 Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT) Status TERMINATED Phase NA
NCT02833350 Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA) Status COMPLETED Phase PHASE2
NCT02808975 Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically Status COMPLETED Phase PHASE4
NCT02764762 Triple Combination Therapy in High Risk Crohn's Disease (CD) Status COMPLETED Phase PHASE4